从回购实施进展来看，普洛药业、恒铭达、南玻A回购金额最高，分别回购3.32亿元、2.73亿元、2.5亿 元。 从已完成回购来看，当日共6家公司回购金额超千万。京东方A、百傲化学、海利得已完成回购金额最 高，分别回购15.0亿元、4.0亿元、1.56亿元。 Wind数据显示，1月6日，70家公司共发布76个股票回购相关进展。其中，2家公司首次披露股票回购预 案，1家公司回购方案获股东大会通过，59家公司披露股票回购实施进展，8家公司回购方案已实施完 毕。 从首次披露回购预案来看，当日共2家公司股票回购预案金额超千万。艾迪精密、科伦药业回购预案金 额最高，分别拟回购不超2.0亿元、1.0亿元。 从股东大会通过回购预案来看，当日共1家公司回购预案超千万。紫燕食品回购金额最高，拟回购不超 1403.25万元。 (本文来自第一财经) ...

格隆汇1月5日丨普洛药业(000739.SZ)公布，截至2025年12月31日，公司通过回购专用证券账户以集中 竞价方式回购公司股份20,370,000股，占公司目前总股本的1.76%，最高成交价为16.85元/股，最低成交 价为15.71元/股，成交总金额为332,025,552.50元（不含交易费用）。本次回购符合公司回购股份方案及 相关法律法规的要求。 ...

（记者 王晓波） 每经AI快讯，普洛药业1月5日晚间发布公告称，截至2025年12月31日，公司通过回购专用证券账户以 集中竞价方式回购公司股份2037万股，占公司目前总股本的1.76%，最高成交价为16.85元/股，最低成 交价为15.71元/股，成交总金额约为3.32亿元。 每经头条（nbdtoutiao）——秒光！1499元飞天茅台上线即空，i茅台App冲上苹果购物榜第一，10万用 户已下单！经销商同价做回馈，1000箱很快卖完 ...

根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9号——回购股份》等相关规定，公司应当在每个月的前三个交易日内，公告截 至上月末的回购进展情况。现将公司回购股份进展情况公告如下： 一、回购股份的进展情况 证券代码：000739 证券简称：普洛药业 公告编号：2026-01 普洛药业股份有限公司 关于回购公司股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 普洛药业股份有限公司（以下简称"公司"）于2025年11月18日召开第九届 董事会第十七次会议审议通过了《关于2025年第二次回购公司股份方案的议案》， 同意公司使用自有资金及金融机构回购贷款通过深圳证券交易所交易系统以集 中竞价交易方式回购公司股份，本次回购股份拟用于股权激励或员工持股计划。 本次回购股份价格不超过人民币23元/股，回购资金总额：不低于人民币18,000 万元（含）且不超过人民币36,000万元（含）。具体回购股份的数量和金额以回 购期限届满或者回购股份实施完毕时实际回购的股份数量和金额为准。回购期限 为自董事会审议通过回购股份方案之日起12个月内。具体内容 ...

Core Viewpoint - In 2025, the pharmaceutical sector in the A-share market is actively engaging in stock buybacks, with many companies opting to destroy the repurchased shares, contrasting with the more subdued actions in the liquor sector [1][10]. Group 1: Buyback Activities - A total of 38 leading pharmaceutical companies participated in stock buybacks, with 6 companies spending over 500 million yuan, and the largest spending 1 billion yuan [1][3]. - WuXi AppTec, a major player in the pharmaceutical outsourcing industry, announced a buyback plan of 1 billion yuan, completing 497 million yuan by April 2025 [2][5]. - Hengrui Medicine, a leader in innovative drugs, announced a buyback plan of 2 billion yuan, having already repurchased 535 million yuan worth of shares by August 2025 [3][6]. - Other notable companies include Jingxin Pharmaceutical, which planned to spend 700 million yuan and has already spent 609 million yuan, and several others like New Harmony, Jiuzan Medical, and Nengte Technology, each spending over 500 million yuan [3][9]. Group 2: Purpose and Impact of Buybacks - The primary purpose of these buybacks is to cancel the repurchased shares, effectively reducing the total share capital and increasing the value of remaining shares for shareholders [4][10]. - This strategy is viewed as a strong signal of management's confidence in the company's future, especially during periods of low market sentiment [5][10]. - The buyback actions are seen as a more tangible commitment to shareholder value compared to merely announcing intentions to stabilize stock prices [4][10]. Group 3: Financial Health and Market Position - The companies engaging in these buybacks, such as WuXi AppTec and Hengrui Medicine, possess strong market positions and cash flows, allowing them to undertake such financial maneuvers [6][10]. - The buyback trend is not as prevalent in the liquor sector, indicating a potential difference in financial strategies and market confidence between the two industries [6][10]. - The buyback prices set by companies reflect a calculated approach, ensuring that they are responsible with shareholder funds [8][10].

Group 1 - The article highlights the development of Hengdian, known as the "Oriental Hollywood," which has become the world's largest film shooting base, generating an annual output value exceeding 35 billion yuan [5][10]. - Hengdian Group, founded 50 years ago, has diversified into various sectors including film and tourism, electronics, and pharmaceuticals, with total assets exceeding 100 billion yuan and six listed companies under its umbrella [5][15][17]. - The founder, Xu Wenrong, and his son, Xu Yong'an, are described as low-profile billionaires, emphasizing that the wealth of Hengdian Group belongs to the collective rather than individuals [6][18]. Group 2 - Hengdian's film industry strategy includes offering free shooting locations to attract film crews, which has led to significant growth in related services such as accommodation and dining, with the film industry generating 15.7 billion yuan in 2020 alone [10][11]. - The Hengdian Film City is projected to receive 15.24 million visitors in 2023, with revenues of 2.638 billion yuan, and 13.93 million visitors in 2024, with revenues of 2.867 billion yuan [11][12]. - Hengdian Film's revenue for 2024 is expected to be 1.971 billion yuan, with nearly 90% coming from cinema operations, while film investment and production contribute 10.3% [12]. Group 3 - Hengdian Group's assets include a general airport and a water plant, with a total revenue of 94.2 billion yuan in 2024 and a net profit of 3.124 billion yuan [17][18]. - The group has a unique corporate structure where ownership is held by community organizations, which has drawn interest from economists [19][20]. - The company is facing challenges in its magnetic materials sector, with market share declining to around 30%, and is adapting to the rise of short dramas in the film industry [24][25]. Group 4 - Hengdian Group is actively seeking transformation, with its photovoltaic sector achieving revenue of 11.47 billion yuan in 2025, a 43.6% increase, becoming a key business segment [25]. - The overall development of Hengdian has significantly improved local income levels, with residents' average annual income reaching 70,000 yuan [25].

Core Viewpoint - Hengdian Group, known as the "Oriental Hollywood," has evolved into the world's largest film shooting base, contributing significantly to the local economy through its diverse business operations, including film and tourism, electronics, and pharmaceuticals [3][24][42]. Group 1: Company Overview - Hengdian Group has transformed from a small silk factory established in 1975 to a large conglomerate with total assets exceeding 100 billion yuan, operating across four major sectors: film and tourism, electronics, pharmaceuticals, and modern services [3][12][36]. - The company has six publicly listed subsidiaries, including Hengdian Film and Television, which is the only listed entity in its film and tourism segment [9][36]. Group 2: Film and Tourism Industry - Hengdian Film City has become a popular destination, attracting over 15 million visitors in 2023 and generating significant revenue from tourism and related services [8][30]. - The decision to waive location fees for film crews since 2000 has led to a surge in film production in Hengdian, with 25% of China's films and 66% of historical dramas being shot there [7][30]. Group 3: Financial Performance - In 2024, Hengdian Group reported revenues of 94.2 billion yuan, with a net profit of 3.12 billion yuan [14][36]. - The film and tourism sector generated approximately 157 billion yuan in revenue in 2020, with tourism income exceeding 20 billion yuan [8][30]. Group 4: Challenges and Adaptation - The company faces challenges such as declining market share in the magnetic materials sector and competition from short-form content in the film industry [20][42]. - Hengdian Group is adapting by investing in new projects, including a 12GW new energy battery project and expanding its film city to cater to changing market demands [21][43].

证券代码：000739 证券简称：普洛药业 公告编号：2025-79 普洛药业股份有限公司 关于对下属公司担保的进展公告 二、担保事项履行的审议程序 公司于 2025 年 3 月 7 日、2025 年 4 月 17 日分别召开了第九届董事会第十 一次会议及 2024 年年度股东大会，审议通过了《关于对下属公司提供担保预计 的议案》，为下属 10 家子公司及孙公司在银行等金融机构的融资提供不超过人 民币 71 亿元的融资担保。本次对外担保额度授权期限为公司 2024 年年度股东大 会审议通过之日起至 2025 年年度股东大会召开之日止。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 1、2025 年 12 月 11 日，普洛药业股份有限公司（以下简称"公司"）与中 国银行股份有限公司东阳支行（以下简称"中国银行"）签订《保证合同》（合 同编号：横店 2025 年人保字 213 号），同意为公司全资子公司浙江普洛家园药 业有限公司（以下简称"家园药业"）与中国银行签署的《商业汇票承兑协议》 （合同编号：横店 2025 年人承字 213 号）中的 ...

Core Viewpoint - The article highlights the transformation of Hengdian, a small town in Zhejiang Province, into the world's largest film and television shooting base, driven by Hengdian Group's strategic investments in the film and tourism industry, resulting in an annual output value exceeding 35 billion yuan [1][3][21]. Group 1: Development of Hengdian - Hengdian Group was founded over 20 years ago, with a vision to create a film shooting location, starting with the construction of "19th Century South Guangdong Guangzhou Street" in just three months for the film "Opium War" [3][4]. - The group has since built over 30 large-scale shooting bases and more than 100 professional studios, making Hengdian the largest film shooting base globally [3][7]. - Hengdian's strategy includes waiving location fees for film crews, which has attracted numerous productions and boosted related industries, including catering, accommodation, and tourism [3][7]. Group 2: Economic Impact - In 2023 and 2024, Hengdian received 15.24 million and 13.93 million tourists, generating revenues of 2.638 billion yuan and 2.867 billion yuan, respectively [7]. - By 2020, Hengdian's film and cultural industry had achieved annual revenues of 15.7 billion yuan, with tourism revenues exceeding 20 billion yuan [7]. - The group has diversified into various sectors, including electronics and pharmaceuticals, with total assets reaching 103.978 billion yuan and revenues of 53.830 billion yuan as of the third quarter of 2025 [10]. Group 3: Unique Corporate Structure - Hengdian Group operates under a unique ownership structure, where wealth is considered collective rather than individual, with significant shares held by community organizations [14][16]. - The group has six publicly listed companies and is a major shareholder in Zhejiang Merchants Bank, holding 4.99% of its shares [9][10]. - The governance model emphasizes collective ownership, which has kept the founders out of personal wealth rankings, focusing instead on community wealth creation [11][12]. Group 4: Challenges and Adaptations - The group faces challenges, including a decline in market share for its magnetic materials from over 60% to around 30%, and the impact of short-form content on traditional film production [18][20]. - Hengdian is adapting by developing new filming environments for short-form content and enhancing visitor experiences through immersive activities and themed hotels [20]. - The group has invested in new projects, including a 12GW high-efficiency battery project and the expansion of Hengdian Airport, with ongoing investments totaling 11.678 billion yuan [19][20].

Core Viewpoint - Hengdian Group has transformed from a small silk factory into a large conglomerate with over 100 billion yuan in total assets, primarily through its film and tourism industry, while also maintaining significant contributions from its electronic and pharmaceutical sectors [4][12][14]. Group 1: Film and Tourism Industry - Hengdian, known as the "Oriental Hollywood," has become the world's largest film shooting base, generating over 35 billion yuan annually from its film and tourism industry [4][6]. - The company offers free filming locations to attract film crews, resulting in a loss of approximately 20 million yuan annually in potential location fees, but this strategy has significantly boosted the local film service and hospitality industries [6][7]. - In 2023 and 2024, Hengdian Film City is expected to receive 15.24 million and 13.93 million visitors, respectively, with revenues of 2.638 billion yuan and 2.867 billion yuan [7]. Group 2: Business Diversification - Hengdian Group operates across four major sectors: film and tourism, electronics, pharmaceuticals, and modern services, with six publicly listed companies under its umbrella [12][14]. - The electronic materials sector, particularly magnetic materials, has historically been a strong revenue driver, although its market share has recently declined to around 30% [22]. - Hengdian Group's pharmaceutical arm, originally established in the 1980s, has also contributed significantly to its overall revenue [10][12]. Group 3: Financial Performance and Assets - In 2024, Hengdian Group is projected to achieve revenues of 94.2 billion yuan, with total assets reaching approximately 1039.78 billion yuan by the end of Q3 2025 [14][22]. - The company has diversified its investments, including a stake in a commercial bank and the establishment of a general airport, which is currently undergoing expansion [14][22]. Group 4: Corporate Structure and Philosophy - Hengdian Group operates under a unique corporate structure where ownership is held by community organizations rather than individual shareholders, reflecting a collective wealth model [18][20]. - The founder, Xu Wenrong, has consistently emphasized that the wealth generated by Hengdian Group belongs to the collective rather than to individuals, which has led to the company's absence from wealth rankings [16][18]. Group 5: Challenges and Adaptation - The rise of short dramas poses a challenge to traditional film productions, prompting Hengdian to adapt by developing dedicated filming locations for shorter formats [22][23]. - Despite facing competition and market pressures, Hengdian Group is actively seeking transformation, particularly in the photovoltaic sector, which has seen significant revenue growth [23].